No designer babies, but summit calls for cautious research
By Lauran Neergaard,
AP
| 12. 03. 2015
[cites CGS' Marcy Darnovsky]
Untitled Document
WASHINGTON (AP) — A tool to edit human genes is nowhere near ready to use for pregnancy — but altering early embryos as part of careful laboratory research should be allowed as scientists and society continue to grapple with the ethical questions surrounding this revolutionary technology, organizers of an international summit concluded Thursday.
"It would be irresponsible" to edit human sperm, eggs or early embryos in a way that leads to pregnancy, said Nobel laureate David Baltimore of the California Institute of Technology, who chaired the summit.
Tools to precisely edit genes inside living cells, especially a cheap and easy-to-use one called CRISP-Cas9, are transforming biology — and potential treatments created by them promise to do such things as cure sickle-cell anemia or fight HIV and cancer.
But depending on how it's used, it also could alter human heredity — maybe create "designer babies" — raising ethical questions that triggered three days of debate by scientists, policymakers and ethicists from 20 countries. This so-called germline editing — manipulating sperm, eggs or early embryos — wouldn't affect just one...
Related Articles
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Neel Shah, The Preprint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Eleanor Hayward and Joanna Crawford, The Times | 03.29.2024
Gazing out at the Mediterranean from an idyllic rocky mountaintop, Sophie Hermann announced to her half a million Instagram followers that she had decided to freeze her eggs. Since that post in August, the 37-year-old former Made in Chelsea star...